{
    "nctId": "NCT04689945",
    "briefTitle": "Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery",
    "officialTitle": "Metabolomic Profiling of Erector Spinae Plane Block for Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 91,
    "primaryOutcomeMeasure": "Metabolomic profiling of ESP block for breast cancer surgery",
    "eligibilityCriteria": "Inclusion criteria:\n\n1. Should be female\n2. Should be between 18-65 years old\n3. Diagnosed with unilateral primary breast cancer\n4. Are decided to have mastectomy surgery\n5. Stage 1-2 breast cancer (T0-1-2, N0-1, M0)\n\nExclusion criteria from the:\n\n1. Being allergic to the anesthetics\n2. Previously had breast operation other than diagnostic biopsy\n3. Presence of a malignancy history on the other breast\n4. Diagnosed with Inflammatory breast cancer\n5. Having a risk score of The American Society of Anaesthesiologists (ASA) risk score 3 and above\n6. Contraindications for regional block(Allergies for local anesthetics, Anatomic application difficulties, Coagulopathies)\n7. Hormone usage\n8. NRS score greater than 3 before the operation\n9. Opioid or steroid usage before the operation\n10. Rheumatologic history\n11. Sickness or drug usage that might cause immunosuppression\n12. Chemotherapy and/or radiotherapy history\n13. Concomitant history of previous malignancy\n14. History of Coronary Artery Disease, Peripheral Vascular Disease that may affect VEGF\n15. Chronic smoking\n16. Chronic obstructive pulmonary disease\n17. Presence of infection at the time of surgery\n18. Hypothalamus, Pituitary, adrenal gland dysfunction\n19. Autoimmune diseases",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}